Drug Trial Radar · NCT05697809
Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema
Last checked: Nov 20, 2026Latest source record: Sep 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3
Actual
Start
Aug 7, 2023
Primary completion
Dec 5, 2024
Study completion Dec 5, 2024
Sponsor
- Lead sponsor
- Oxular LimitedIndustry
- Sponsor type
- Industry
- First posted
- Jan 26, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical trial is to compare safety, tolerability, efficacy, and durability of two dose levels of suprachoroidal sustained-release OXU-001 (dexamethasone microspheres; DEXAspheres®) using the Oxulumis® illuminated microcatheterization device compared with intravitreal dexamethasone implant (OZURDEX®) in subjects with diabetic macular edema.
Conditions
- Diabetic Macular Edema
Interventions
OXU-001Drug
Suprachoroidal sustained release dexamethasone acetate
Semi-automated suprachoroidal illuminated microcatheterDevice
Ophthalmic administration device
Ozurdex® Ophthalmic Intravitreal ImplantDrug
Ophthalmic dexamethasone intravitreal implant
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency and Severity of Ocular and Systemic Treatment Emergent Adverse Events, Serious Adverse Events, and Adverse Events of Special InterestTime frame: Day 0 up to Week 52
- Frequency and Severity of Treatment-emergent Adverse Device EffectsTime frame: Day 0 up to Week 52
Locations
9 sites in 2 countries. Site status is shown where the registry gives one.
Retinal Research Institute, LLC
Phoenix, Arizona
Blue Ocean Clinical Research West
Clearwater, Florida
University Retina and Macula Associates
Oak Forest, Illinois
Retina Consultants of Minnesota
Minneapolis, Minnesota
Sierra Eye Associates
Reno, Nevada
Retina Consultants of Texas
Houston, Texas
Valley Retina Institute, PA
McAllen, Texas
Retinal Consultants of Texas - San Antonio
San Antonio, Texas
Emmanuelli Research and Development Center, LLC
Arecibo, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.